Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vernalis appoints new CEO and CFO

This article was originally published in Scrip

Executive Summary

Vernalishas appointed Ian Garland chief executive officer, effective December, and David Mackney chief financial officer, effective February 2009. From May 2007 until September 2008, Mr Garland was CEO of Acambis. He has also served as CFO of Arrow Therapeutics, and as president and chief operating officer of Celltech Pharmaceuticals. From February 2008 to date, Mr Mackney has served as interim CFO at Acambis, working with Mr Garland to secure the US biodefence contract and the secondary financing. Before this he was CFO for a private equity-backed technology company.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC031647

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel